title: Psoriasiform eruption triggered by recombinant granulocyte-macrophage colony stimulating factor (rGM-CSF) and exacerbated by granulocyte colony stimulating factor (rG-CSF) in a patient with breast cancer.
abstract: Colony-stimulating factors (CSFs) are commonly used for the treatment of neutropenia following chemotherapy and for the mobilization of peripheral blood stem cells (PBSC). We recently experienced a rare case of a new onset of psoriasiform eruption by GM-CSF (granulocyte-macrophage colony-stimulating factor) which was exacerbated by G-CSF (granulocyte colony-stimulating factor) in a patient with breast cancer. A 36-year-old woman had received neoadjuvant chemotherapy (cyclophosphamide, epirubicin and 5-fluorouracil), modified radical mastectomy and adjuvant chemotherapy with paclitaxel and mitoxantrone followed by GM-CSF administration for the treatment of locally advanced breast cancer. She had developed a psoriatic skin lesion on face and both upper arms during leukocyte recovery in spite of no previous history of psoriasis. Next, the chemotherapy course was complicated by a flare of mild psoriatic skin lesion, although CSF was changed into G-CSF due to GM-CSF-associated psoriasis. Subsequently, she had had high-dose chemotherapy and autologous peripheral blood stem cell transplantation for consolidation therapy. GM-CSF was administered for the mobilization of PBSC and post-transplant period, but psoriatic skin lesion did not appear. During 6 months after PBSCT, psoriasiform eruption did not appear.
authors.affiliation: Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul.
authors.forename: S G
authors.initials: SG
authors.lastname: Cho
authors.forename: Y M
authors.initials: YM
authors.lastname: Park
authors.forename: H
authors.initials: H
authors.lastname: Moon
authors.forename: K M
authors.initials: KM
authors.lastname: Kim
authors.forename: S S
authors.initials: SS
authors.lastname: Bae
authors.forename: G B
authors.initials: GB
authors.lastname: Kim
authors.forename: H S
authors.initials: HS
authors.lastname: Cho
authors.forename: C C
authors.initials: CC
authors.lastname: Kim
authors.forename: K S
authors.initials: KS
authors.lastname: Lee
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy*; D018270:Carcinoma, Ductal, Breast / Q000150:complications / Q000188:drug therapy; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects*; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy; D011565:Psoriasis / Q000139:chemically induced*; D011994:Recombinant Proteins
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor